Valeritas (Bridgewater, NJ) a commercial-stage developer of a disposable insulin delivery device, closed a $150M Series C financing. Participants include Welsh, Carson, Anderson & Stowe, MPM Capital, Pitango Venture Capital, Abingworth Management, Advanced Technology Ventures, Onset Ventures, HLM Venture Partners, Agate Medical Investments, CHL Medical Partners and Kaiser Permanente Ventures.

DICOM Grid (Phoenix, AZ) a development-stage bioinformatics company focused on the development of medical imaging software, closed a $7.5M Series A financing. Participants include Canaan Partners and CHL Medical Partners.

Vascular Pathways (Los Altos, CA) a clinical-stage medical device company focused on rapid peripheral intravenous access, closed a $14M Series B financing. Participants include CHL Medical Partners, Ascension Health Ventures, MVM Life Science Partners and Arcus Ventures.

OpGen (Gaithersburg, MD) a commercial-stage genomics device company focused on optical mapping combining strain typing and sequencing, closed a $17M Series B round financing. Participants include jVen Capital, CHL Medical Partners, Highland Capital Partners, Mason Wells Biomedical and Versant Ventures.

Vertos Medical (Aliso Viejo, CA) a commercial stage medical device company focused on providing minimally invasive alternatives for surgical procedures to treat lumbar spinal stenosis, closed a $15.5M Series D financing. Participants include Onset Ventures, CHL Medical Partners, Foundation Medical Partners, Aweida Venture Partners and DFJ Mercury.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.

PrimeraDx (Mansfield, MA) a development-stage molecular diagnostics company focused on automated multiplexed assays of infectious disease testing in immune compromised patients undergoing solid organ and bone marrow transplant, closed a $20M Series C financing. Participants include CHL Medical Partners, Abingworth, InterWest Partners, Malaysian Technology Development Corporation, MPM Capital, Burrill & Co. and Invus.